Ultrasound-guided Versus Blind Technique in Medial Brachial Cutaneous Nerve and Intercostobrachial Nerve Blocks
Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Oct 19, 2016
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
For purposes of this single-blind monocentric study, 84 patients are randomized into two groups (42 patients for each), upon enrolment into the study.
In the first group, the blind technique is used to perform the medial brachial cutaneous nerve block and the intercostobrachial nerve block : it consists in performing a subcutaneous injection of the local anesthetic at the root of the arm, in the anterior-posterior direction.
In the second group, the ultrasound-guided technique is used to perform the medial brachial cutaneous nerve block and the intercostobrachial nerve block : ultrasounds...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients ≥ 18 years
- • Surgery of the distal upper limb : hand, forearm, lower third of the arm ,including the elbow
- • Urgent or planned surgery
- • Locoregional anesthesia : axillary brachial plexus block, completed by a medial brachial cutaneous nerve block and an intercostobrachial nerve block
- • Local anesthetic used : mepivacaine 10mg/ml
- • In the absence of patient objections
- Exclusion Criteria:
- • Pregnancy
- • Adults under guardianship
- • Locoregional anesthesia contraindications
- • Local anesthetic used : ropivacaine 0,75%
About Central Hospital, Nancy, France
Central Hospital, located in Nancy, France, is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes. As a prominent clinical trial sponsor, the hospital is committed to conducting innovative studies across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Central Hospital leverages its state-of-the-art facilities and expertise to contribute to the development of cutting-edge treatments and enhance the overall quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nancy, , France
Patients applied
Trial Officials
Hervé BOUAZIZ, Professor
Study Director
CHU Nancy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials